After receiving treatment for acute myeloid leukemia, Steve underwent a stem cell transplant to decrease the odds of the cancer returning. Following the transplant, his journey was complicated with a diagnosis of veno-occlusive disease.
How Stem Cell Transplantation Can Improve Outcomes for Patients With Blood Cancers
Blood cancer patients may endure aggressive chemotherapy that inadvertently destroys healthy cells—hematopoietic stem cell transplantation is an attractive option for appropriate patients that can help prolong survival following chemotherapy.
Jazz strives to create a workplace culture that supports a diverse, multicultural workforce and provides an inclusive environment where all employees are empowered to contribute and succeed.
Low Intensity Therapy for first-line, unfit AML (Phase 1b)
CPX-351 + various targeted agents
First-line, fit AML (Phase 1b)
CPX-3513
Low Intensity Dosing for higher risk MDS
IMGN6321
CD123+ Hematological malignancies
IMGN632 +/- venetoclax/azacitidine1
CD123+ AML (Phase 1b/2)
PHASE 2
JZP-3854
Essential tremor (Phase 2b)
Defibrotide
Prevention of aGvHD
Defibrotide
Prevention of CAR-T associated neurotoxicity
CPX-351 + venetoclax3
de novo or R/R AML
CPX-3515
HR-MDS (EMSCO)
CPX-3515
R/R AML (COG)
CPX-3514,5
Newly diagnosed older adults with HR-AML
CPX-351 + venetoclax4,5
HR-AML
PHASE 3
JZP-258
Idiopathic hypersomnia
Solriamfetol
EDS in MDD4
Defibrotide
Prevention of VOD
CPX-3515
AML or HR-MDS (AML19 & AML18)
CPX-3515
Newly diagnosed adults with standard- and HR-AML (AMLSG)
CPX-3514,5
Newly diagnosed pediatric patients (COG)
Lurbinectedin6
Relapsed SCLC (ATLANTIS)
JZP-458 (recombinant Erwinia asparaginase)
ALL/LBL (pivotal Phase 2/3)
REGULATORY
JZP-258
Cataplexy & EDS in narcolepsy4
Lurbinectedin6
Relapsed SCLC
Neuroscience
Hematology/Oncology
1Opt-in opportunity
2Partnered collaboration
3Jazz & MD Anderson Cancer Center collaboration study
4Planned
5Cooperative group study
6Exclusive U.S. license
Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully.
By unlocking biopharmaceutical discoveries to develop novel medicines, we are giving thousands of people around the world the opportunity to redefine what’s possible.
Thank you for contacting Jazz Pharmaceuticals Corporate Development & Partnering
Sending data...
Contact Corporate Development / Partnering
Personal Information(All fields are required)
Please provide details on this opportunity
This website uses cookies to help us provide you with a more responsive and
personalized service. By using this website without changing your cookie
settings, you agree to our use of cookies. For more information on how
we use cookies and how to delete or block the use of cookies, please
see our Privacy Statement. By clicking on Accept you consent to our use of cookies.
Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue.
